United States · FDA National Drug Code directory
Migraine Headache Therapy
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17312-041_4604cabb-ce20-ae65-e063-6394a90a200e
- Product NDC
- 17312-041
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- ATROPA BELLADONNA - BRYONIA ALBA ROOT - BLACK COHOSH - ARABICA COFFEE BEAN - NITROGLYCERIN - IRIS VERSICOLOR ROOT - SODIUM CHLORIDE -
- Labeler
- TRP Company
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20160401
- Source listing expiry
- 20261231
Source-listed ingredients
- ATROPA BELLADONNA — 6 [hp_X]/1
- BRYONIA ALBA ROOT — 6 [hp_X]/1
- BLACK COHOSH — 6 [hp_X]/1
- ARABICA COFFEE BEAN — 3 [hp_X]/1
- NITROGLYCERIN — 12 [hp_X]/1
- IRIS VERSICOLOR ROOT — 6 [hp_X]/1
- SODIUM CHLORIDE — 6 [hp_X]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 PACKAGE (17312-041-14) / 50 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · 17312-041-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →